{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:46:34Z","timestamp":1776246394842,"version":"3.50.1"},"reference-count":76,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2019]]},"DOI":"10.2222\/jsv.69.13","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T22:07:05Z","timestamp":1600207625000},"page":"13-22","source":"Crossref","is-referenced-by-count":1,"title":["EBV and Lymphomagenesis","EB\u30a6\u30a4\u30eb\u30b9\u3068\u30ea\u30f3\u30d1\u816b\u539f\u6027"],"prefix":"10.2222","volume":"69","author":[{"given":"Hiroshi","family":"KIMURA","sequence":"first","affiliation":[{"name":"Department of Virology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"OKUNO","sequence":"additional","affiliation":[{"name":"Medical Genomics Center, Nagoya University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","unstructured":"1\uff09 R. Longnecker, E. Kieff, and J.I. Cohen, Epstein-Barr virus. in: D.M. Knipe, and P.M. Howley, (Eds.), Fields Virology, Lippincott Williams & Willkins, Philadelphia, 2013, pp. 1898-1959."},{"key":"2","unstructured":"2\uff09 J.I. Cohen, H. Kimura, S. Nakamura, Y.H. Ko, and E.S. Jaffe, Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol 20 (2009) 1472-82."},{"key":"3","unstructured":"3\uff09 S.H. Swerdlow, E. Campo, S.A. Pileri, N.L. Harris, H. Stein, R. Siebert, R. Advani, M. Ghielmini, G.A. Salles, A.D. Zelenetz, and E.S. Jaffe, The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127 (2016) 2375-90."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4\uff09 R.J. Peng, B.W. Han, Q.Q. Cai, X.Y. Zuo, T. Xia, J.R. Chen, L.N. Feng, J.Q. Lim, S.W. Chen, M.S. Zeng, Y.M. Guo, B. Li, X.J. Xia, Y. Xia, Y. Laurensia, B.K.H. Chia, H.Q. Huang, K.H. Young, S.T. Lim, C.K. Ong, Y.X. Zeng, and J.X. Bei, Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma. Leukemia (2018).","DOI":"10.1038\/s41375-018-0324-5"},{"key":"5","unstructured":"5\uff09 Y. Okuno, T. Murata, Y. Sato, H. Muramatsu, Y. Ito, T. Watanabe, T. Okuno, N. Murakami, K. Yoshida, A. Sawada, M. Inoue, K. Kawa, M. Seto, K. Ohshima, Y. Shiraishi, K. Chiba, H. Tanaka, S. Miyano, Y. Narita, M. Yoshida, F. Goshima, J.I. Kawada, T. Nishida, H. Kiyoi, S. Kato, S. Nakamura, S. Morishima, T. Yoshikawa, S. Fujiwara, N. Shimizu, Y. Isobe, M. Noguchi, A. Kikuta, K. Iwatsuki, Y. Takahashi, S. Kojima, S. Ogawa, and H. Kimura, Defective Epstein-Barr virus in chronic active infection and haematological malignancy. Nat Microbiol 4 (2019) 404-413."},{"key":"6","unstructured":"6\uff09 L.M. Hutt-Fletcher, Epstein-Barr virus entry. J Virol 81 (2007) 7825-32."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7\uff09 T. Murata, Encyclopedia of EBV-Encoded Lytic Genes: An Update. Human Herpesviruses 1045 (2018) 395-412.","DOI":"10.1007\/978-981-10-7230-7_18"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8\uff09 Y. Sato, T. Watanabe, C. Suzuki, Y. Abe, H. Masud, T. Inagaki, M. Yoshida, T. Suzuki, F. Goshima, J. Adachi, T. Tomonaga, T. Murata, and H. Kimura, S-Like-Phase Cyclin-Dependent Kinases Stabilize the Epstein-Barr Virus BDLF4 Protein To Temporally Control Late Gene Transcription. J Virol 93 (2019) e01707-18.","DOI":"10.1128\/JVI.01707-18"},{"key":"9","unstructured":"9\uff09 K.R. Katsumura, S. Maruo, and K. Takada, EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes. J Med Virol 84 (2012) 504-10."},{"key":"10","unstructured":"10\uff09 S.D. Ma, S. Hegde, K.H. Young, R. Sullivan, D. Rajesh, Y. Zhou, E. Jankowska-Gan, W.J. Burlingham, X. Sun, M.L. Gulley, W. Tang, J.E. Gumperz, and S.C. Kenney, A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol 85 (2011) 165-77."},{"key":"11","unstructured":"11\uff09 T. Murata, Y. Sato, and H. Kimura, Modes of infection and oncogenesis by the Epstein-Barr virus. Rev Med Virol 24 (2014) 242-53."},{"key":"12","unstructured":"12\uff09 T. Yamamoto, Y. Hirai, T. Miyake, T. Hamada, O. Yamasaki, S. Morizane, W. Fujimoto, and K. Iwatsuki, Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites. J Dermatol Sci 82 (2016) 153-9."},{"key":"13","unstructured":"13\uff09 M. Cohen, A.G. Vistarop, F. Huaman, M. Narbaitz, F. Metrebian, E. De Matteo, M.V. Preciado, and P.A. Chabay, Epstein-Barr virus lytic cycle involvement in diffuse large B cell lymphoma. Hematol Oncol 36 (2018) 98-103."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14\uff09 T. Kanda, EBV-Encoded Latent Genes. Human Herpesviruses 1045 (2018) 377-394.","DOI":"10.1007\/978-981-10-7230-7_17"},{"key":"15","unstructured":"15\uff09 T. Ito, H. Kawazu, T. Murata, S. Iwata, S. Arakawa, Y. Sato, K. Kuzushima, F. Goshima, and H. Kimura, Role of latent membrane protein 1 in chronic active Epstein-Barr virus infection-derived T\/NK-cell proliferation. Cancer Med 3 (2014) 787-95."},{"key":"16","unstructured":"16\uff09 T. Murata, C. Noda, Y. Narita, T. Watanabe, M. Yoshida, K. Ashio, Y. Sato, F. Goshima, T. Kanda, H. Yoshiyama, T. Tsurumi, and H. Kimura, Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor. J Virol 90 (2016) 3873-89."},{"key":"17","unstructured":"17\uff09 Y. Sato, S. Ochiai, T. Murata, T. Kanda, F. Goshima, and H. Kimura, Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cells. Oncotarget 8 (2017) 39345-39355."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18\uff09 A.D. Hislop, G.S. Taylor, D. Sauce, and A.B. Rickinson, Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 25 (2007) 587-617.","DOI":"10.1146\/annurev.immunol.25.022106.141553"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19\uff09 H. Kimura, EBV in T-\/NK-Cell Tumorigenesis. Adv Exp Med Biol 1045 (2018) 459-475.","DOI":"10.1007\/978-981-10-7230-7_21"},{"key":"20","unstructured":"20\uff09 T. Minamitani, Y. Ma, H. Zhou, H. Kida, C.Y. Tsai, M. Obana, D. Okuzaki, Y. Fujio, A. Kumanogoh, B. Zhao, H. Kikutani, E. Kieff, B.E. Gewurz, and T. Yasui, Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease. Proc Natl Acad Sci U S A 114 (2017) 4751-4756."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21\uff09 O. Klinke, R. Feederle, and H.J. Delecluse, Genetics of Epstein-Barr virus microRNAs. Semin Cancer Biol 26 (2014) 52-9.","DOI":"10.1016\/j.semcancer.2014.02.002"},{"key":"22","unstructured":"22\uff09 L. Leoncini, E. Campo, H. Stein, N.L. Harris, E.S. Jaffe, and P.M. Kluin, Burkitt lymphoma. in: S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, and J. Thiele, (Eds.), WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. , WHO IARC Press, Lyon, 2016, pp. 330-334."},{"key":"23","unstructured":"23\uff09 B.E. Griffin, and R. Rochford, Endemic Burkitt's Lymphoma. in: E.S. Robertson, (Ed.), Epstein-Barr virus, Caister Academic Press, Norfork, 2005, pp. 113-138."},{"key":"24","unstructured":"24\uff09 D.F. Robbiani, A. Bothmer, E. Callen, B. Reina-San-Martin, Y. Dorsett, S. Difilippantonio, D.J. Bolland, H.T. Chen, A.E. Corcoran, A. Nussenzweig, and M.C. Nussenzweig, AID is required for the chromosomal breaks in c-myc that lead to c-myc\/IgH translocations. Cell 135 (2008) 1028-38."},{"key":"25","unstructured":"25\uff09 T. Honjo, M. Muramatsu, and S. Fagarasan, AID: how does it aid antibody diversity? Immunity 20 (2004) 659-68."},{"key":"26","unstructured":"26\uff09 I.M. Okazaki, H. Hiai, N. Kakazu, S. Yamada, M. Muramatsu, K. Kinoshita, and T. Honjo, Constitutive expression of AID leads to tumorigenesis. J Exp Med 197 (2003) 1173-81."},{"key":"27","unstructured":"27\uff09 M. Epeldegui, Y.P. Hung, A. McQuay, R.F. Ambinder, and O. Martinez-Maza, Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol Immunol 44 (2007) 934-42."},{"key":"28","unstructured":"28\uff09 B. He, N. Raab-Traub, P. Casali, and A. Cerutti, EBV-encoded latent membrane protein 1 cooperates with BAFF\/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J Immunol 171 (2003) 5215-24."},{"key":"29","unstructured":"29\uff09 J.H. Kim, W.S. Kim, and C. Park, Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphoma. Leuk Lymphoma 54 (2013) 2035-40."},{"key":"30","unstructured":"30\uff09 S.H. Chiu, C.C. Wu, C.Y. Fang, S.L. Yu, H.Y. Hsu, Y.H. Chow, and J.Y. Chen, Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma. Oncotarget 5 (2014) 8583-601."},{"key":"31","unstructured":"31\uff09 C.C. Wu, M.T. Liu, Y.T. Chang, C.Y. Fang, S.P. Chou, H.W. Liao, K.L. Kuo, S.L. Hsu, Y.R. Chen, P.W. Wang, Y.L. Chen, H.Y. Chuang, C.H. Lee, M. Chen, W.S. Wayne Chang, and J.Y. Chen, Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells. Nucleic Acids Res 38 (2010) 1932-49."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32\uff09 O. Manners, J.C. Murphy, A. Coleman, D.J. Hughes, and A. Whitehouse, Contribution of the KSHV and EBV lytic cycles to tumourigenesis. Curr Opin Virol 32 (2018) 60-70.","DOI":"10.1016\/j.coviro.2018.08.014"},{"key":"33","unstructured":"33\uff09 M. Nakamura, S. Iwata, H. Kimura, and Y. Tokura, Elevated expression of activation-induced cytidine deaminase in T and NK cells from patients with chronic active Epstein-Barr virus infection. Eur J Dermatol 21 (2011) 780-2."},{"key":"34","unstructured":"34\uff09 K. Ohshima, J. Suzumiya, S. Ohga, A. Ohgami, and M. Kikuchi, Integrated Epstein-Barr virus (EBV) and chromosomal abnormality in chronic active EBV infection. Int J Cancer 71 (1997) 943-7."},{"key":"35","unstructured":"35\uff09 H. Kimura, Y. Hoshino, H. Kanegane, I. Tsuge, T. Okamura, K. Kawa, and T. Morishima, Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 98 (2001) 280-6."},{"key":"36","unstructured":"36\uff09 M. Nakamura, K. Sugita, Y. Sawada, R. Yoshiki, R. Hino, and Y. Tokura, High levels of activation-induced cytidine deaminase expression in adult T-cell leukaemia\/lymphoma. Br J Dermatol 165 (2011) 437-9."},{"key":"37","unstructured":"37\uff09 C. Ishikawa, S. Nakachi, M. Senba, M. Sugai, and N. Mori, Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis. Carcinogenesis 32 (2011) 110-9."},{"key":"38","unstructured":"38\uff09 J. Fan, G. Ma, K. Nosaka, J. Tanabe, Y. Satou, A. Koito, S. Wain-Hobson, J.P. Vartanian, and M. Matsuoka, APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo. J Virol 84 (2010) 7278-87."},{"key":"39","unstructured":"39\uff09 C. Kandoth, M.D. McLellan, F. Vandin, K. Ye, B. Niu, C. Lu, M. Xie, Q. Zhang, J.F. McMichael, M.A. Wyczalkowski, M.D.M. Leiserson, C.A. Miller, J.S. Welch, M.J. Walter, M.C. Wendl, T.J. Ley, R.K. Wilson, B.J. Raphael, and L. Ding, Mutational landscape and significance across 12 major cancer types. Nature 502 (2013) 333-339."},{"key":"40","unstructured":"40\uff09 R. Schmitz, R.M. Young, M. Ceribelli, S. Jhavar, W. Xiao, M. Zhang, G. Wright, A.L. Shaffer, D.J. Hodson, E. Buras, X. Liu, J. Powell, Y. Yang, W. Xu, H. Zhao, H. Kohlhammer, A. Rosenwald, P. Kluin, H.K. Muller-Hermelink, G. Ott, R.D. Gascoyne, J.M. Connors, L.M. Rimsza, E. Campo, E.S. Jaffe, J. Delabie, E.B. Smeland, M.D. Ogwang, S.J. Reynolds, R.I. Fisher, R.M. Braziel, R.R. Tubbs, J.R. Cook, D.D. Weisenburger, W.C. Chan, S. Pittaluga, W. Wilson, T.A. Waldmann, M. Rowe, S.M. Mbulaiteye, A.B. Rickinson, and L.M. Staudt, Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490 (2012) 116-20."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41\uff09 F. Abate, M.R. Ambrosio, L. Mundo, M.A. Laginestra, F. Fuligni, M. Rossi, S. Zairis, S. Gazaneo, G. De Falco, S. Lazzi, C. Bellan, B.J. Rocca, T. Amato, E. Marasco, M. Etebari, M. Ogwang, V. Calbi, I. Ndede, K. Patel, D. Chumba, P.P. Piccaluga, S. Pileri, L. Leoncini, and R. Rabadan, Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma. PLoS Pathog 11 (2015) e1005158.","DOI":"10.1371\/journal.ppat.1005158"},{"key":"42","unstructured":"42\uff09 B.M. Grande, D.S. Gerhard, A. Jiang, N.B. Griner, J.S. Abramson, T.B. Alexander, H. Allen, L.W. Ayers, J.M. Bethony, K. Bhatia, J. Bowen, C. Casper, J.K. Choi, L. Culibrk, T.M. Davidsen, M.A. Dyer, J.M. Gastier-Foster, P. Gesuwan, T.C. Greiner, T.G. Gross, B. Hanf, N.L. Harris, Y. He, J.D. Irvin, E.S. Jaffe, S.J.M. Jones, P. Kerchan, N. Knoetze, F.E. Leal, T.M. Lichtenberg, Y. Ma, J.P. Martin, M.R. Martin, S.M. Mbulaiteye, C.G. Mullighan, A.J. Mungall, C. Namirembe, K. Novik, A. Noy, M.D. Ogwang, A. Omoding, J. Orem, S.J. Reynolds, C.K. Rushton, J.T. Sandlund, R. Schmitz, C. Taylor, W.H. Wilson, G.W. Wright, E.Y. Zhao, M.A. Marra, R.D. Morin, and L.M. Staudt, Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood 133 (2019) 1313-1324."},{"key":"43","unstructured":"43\uff09 T. Osato, F. Mizuno, S. Imai, T. Aya, S. Koizumi, T. Kinoshita, H. Tokuda, Y. Ito, N. Hirai, M. Hirota, and et al., African Burkitt's lymphoma and an Epstein-Barr virus-enhancing plant Euphorbia tirucalli. Lancet 1 (1987) 1257-8."},{"key":"44","unstructured":"44\uff09 L. Pasqualucci, V. Trifonov, G. Fabbri, J. Ma, D. Rossi, A. Chiarenza, V.A. Wells, A. Grunn, M. Messina, O. Elliot, J. Chan, G. Bhagat, A. Chadburn, G. Gaidano, C.G. Mullighan, R. Rabadan, and R. Dalla-Favera, Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 43 (2011) 830-7."},{"key":"45","unstructured":"45\uff09 L. Jiang, Z.H. Gu, Z.X. Yan, X. Zhao, Y.Y. Xie, Z.G. Zhang, C.M. Pan, Y. Hu, C.P. Cai, Y. Dong, J.Y. Huang, L. Wang, Y. Shen, G. Meng, J.F. Zhou, J.D. Hu, J.F. Wang, Y.H. Liu, L.H. Yang, F. Zhang, J.M. Wang, Z. Wang, Z.G. Peng, F.Y. Chen, Z.M. Sun, H. Ding, J.M. Shi, J. Hou, J.S. Yan, J.Y. Shi, L. Xu, Y. Li, J. Lu, Z. Zheng, W. Xue, W.L. Zhao, Z. Chen, and S.J. Chen, Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma. Nat Genet 47 (2015) 1061-6."},{"key":"46","doi-asserted-by":"crossref","unstructured":"46\uff09 A. Dobashi, N. Tsuyama, R. Asaka, Y. Togashi, K. Ueda, S. Sakata, S. Baba, K. Sakamoto, K. Hatake, and K. Takeuchi, Frequent BCOR aberrations in extranodal NK\/T-Cell lymphoma, nasal type. Genes Chromosomes Cancer 55 (2016) 460-71.","DOI":"10.1002\/gcc.22348"},{"key":"47","unstructured":"47\uff09 T. Kanda, M. Yajima, and K. Ikuta, Epstein-Barr virus strain variation and cancer. Cancer Sci 110 (2019) 1132-1139."},{"key":"48","unstructured":"48\uff09 A. Hildesheim, R.J. Apple, C.J. Chen, S.S. Wang, Y.J. Cheng, W. Klitz, S.J. Mack, I.H. Chen, M.M. Hsu, C.S. Yang, L.A. Brinton, P.H. Levine, and H.A. Erlich, Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 94 (2002) 1780-9."},{"key":"49","unstructured":"49\uff09 M. Niens, R.F. Jarrett, B. Hepkema, I.M. Nolte, A. Diepstra, M. Platteel, N. Kouprie, C.P. Delury, A. Gallagher, L. Visser, S. Poppema, G.J. te Meerman, and A. van den Berg, HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma. Blood 110 (2007) 3310-5."},{"key":"50","unstructured":"50\uff09 Y. Ito, R. Suzuki, Y. Torii, K. Kawa, A. Kikuta, S. Kojima, and H. Kimura, HLA-A*26 and HLA-B*52 are associated with a risk of developing EBV-associated T\/NK lymphoproliferative disease. Blood e-Letter bloodjournal_el; 8085 (2013)."},{"key":"51","unstructured":"51\uff09 H. Kimura, Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol 16 (2006) 251-61."},{"key":"52","unstructured":"52\uff09 H. Kimura, and J.I. Cohen, Chronic Active Epstein-Barr Virus Disease. Front Immunol 8 (2017) 1867."},{"key":"53","unstructured":"53\uff09 L. Quintanilla-Martinez, Y.H. Ko, H. Kimura, and E.S. Jaffe, EBV\u2013positive T-cell and NK-cell lymphoproliferative diseases of childhood. in: S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, and J. Thiele, (Eds.), WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, WHO IARC Press, Lyon, 2017, pp. 355-362."},{"key":"54","unstructured":"54\uff09 H. Kimura, T. Morishima, H. Kanegane, S. Ohga, Y. Hoshino, A. Maeda, S. Imai, M. Okano, T. Morio, S. Yokota, S. Tsuchiya, A. Yachie, S. Imashuku, K. Kawa, and H. Wakiguchi, Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 187 (2003) 527-33."},{"key":"55","unstructured":"55\uff09 H. Kimura, Y. Ito, S. Kawabe, K. Gotoh, Y. Takahashi, S. Kojima, T. Naoe, S. Esaki, A. Kikuta, A. Sawada, K. Kawa, K. Ohshima, and S. Nakamura, EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 119 (2012) 673-86."},{"key":"56","unstructured":"56\uff09 C.M. Cruciat, C. Dolde, R.E. de Groot, B. Ohkawara, C. Reinhard, H.C. Korswagen, and C. Niehrs, RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-beta-catenin signaling. Science 339 (2013) 1436-41."},{"key":"57","unstructured":"57\uff09 K. Kataoka, Y. Shiraishi, Y. Takeda, S. Sakata, M. Matsumoto, S. Nagano, T. Maeda, Y. Nagata, A. Kitanaka, S. Mizuno, H. Tanaka, K. Chiba, S. Ito, Y. Watatani, N. Kakiuchi, H. Suzuki, T. Yoshizato, K. Yoshida, M. Sanada, H. Itonaga, Y. Imaizumi, Y. Totoki, W. Munakata, H. Nakamura, N. Hama, K. Shide, Y. Kubuki, T. Hidaka, T. Kameda, K. Masuda, N. Minato, K. Kashiwase, K. Izutsu, A. Takaori-Kondo, Y. Miyazaki, S. Takahashi, T. Shibata, H. Kawamoto, Y. Akatsuka, K. Shimoda, K. Takeuchi, T. Seya, S. Miyano, and S. Ogawa, Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers. Nature 534 (2016) 402-6."},{"key":"58","unstructured":"58\uff09 T. Okazaki, S. Chikuma, Y. Iwai, S. Fagarasan, and T. Honjo, A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application. Nat Immunol 14 (2013) 1212-8."},{"key":"59","doi-asserted-by":"crossref","unstructured":"59\uff09 K. Kataoka, H. Miyoshi, S. Sakata, A. Dobashi, L. Couronne, Y. Kogure, Y. Sato, K. Nishida, Y. Gion, Y. Shiraishi, H. Tanaka, K. Chiba, Y. Watatani, N. Kakiuchi, Y. Shiozawa, T. Yoshizato, K. Yoshida, H. Makishima, M. Sanada, M. Onozawa, T. Teshima, Y. Yoshiki, T. Ishida, K. Suzuki, K. Shimada, A. Tomita, M. Kato, Y. Ota, K. Izutsu, A. Demachi-Okamura, Y. Akatsuka, S. Miyano, T. Yoshino, P. Gaulard, O. Hermine, K. Takeuchi, K. Ohshima, and S. Ogawa, Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas. Leukemia (2019).","DOI":"10.1038\/s41375-019-0380-5"},{"key":"60","unstructured":"60\uff09 E. Anastasiadou, D. Stroopinsky, S. Alimperti, A.L. Jiao, A.R. Pyzer, C. Cippitelli, G. Pepe, M. Severa, J. Rosenblatt, M.P. Etna, S. Rieger, B. Kempkes, E.M. Coccia, S.J.H. Sui, C.S. Chen, S. Uccini, D. Avigan, A. Faggioni, P. Trivedi, and F.J. Slack, Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas. Leukemia 33 (2019) 132-147."},{"key":"61","unstructured":"61\uff09 X.W. Bi, H. Wang, W.W. Zhang, J.H. Wang, W.J. Liu, Z.J. Xia, H.Q. Huang, W.Q. Jiang, Y.J. Zhang, and L. Wang, PD-L1 is upregulated by EBV-driven LMP1 through NF-kappaB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma. J Hematol Oncol 9 (2016) 109."},{"key":"62","unstructured":"62\uff09 W. Fang, J. Zhang, S. Hong, J. Zhan, N. Chen, T. Qin, Y. Tang, Y. Zhang, S. Kang, T. Zhou, X. Wu, W. Liang, Z. Hu, Y. Ma, Y. Zhao, Y. Tian, Y. Yang, C. Xue, Y. Yan, X. Hou, P. Huang, Y. Huang, H. Zhao, and L. Zhang, EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy. Oncotarget 5 (2014) 12189-202."},{"key":"63","unstructured":"63\uff09 Y.L. Kwong, T.S.Y. Chan, D. Tan, S.J. Kim, L.M. Poon, B. Mow, P.L. Khong, F. Loong, R. Au-Yeung, J. Iqbal, C. Phipps, and E. Tse, PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase. Blood 129 (2017) 2437-2442."},{"key":"64","unstructured":"64\uff09 R.W. Merryman, P. Armand, K.T. Wright, and S.J. Rodig, Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma. Blood Adv 1 (2017) 2643-2654."},{"key":"65","unstructured":"65\uff09 P.S. Moore, and Y. Chang, Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 10 (2010) 878-89."},{"key":"66","unstructured":"66\uff09 M. Narisawa-Saito, and T. Kiyono, Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci 98 (2007) 1505-11."},{"key":"67","unstructured":"67\uff09 K. Kataoka, Y. Nagata, A. Kitanaka, Y. Shiraishi, T. Shimamura, J. Yasunaga, Y. Totoki, K. Chiba, A. Sato-Otsubo, G. Nagae, R. Ishii, S. Muto, S. Kotani, Y. Watatani, J. Takeda, M. Sanada, H. Tanaka, H. Suzuki, Y. Sato, Y. Shiozawa, T. Yoshizato, K. Yoshida, H. Makishima, M. Iwanaga, G. Ma, K. Nosaka, M. Hishizawa, H. Itonaga, Y. Imaizumi, W. Munakata, H. Ogasawara, T. Sato, K. Sasai, K. Muramoto, M. Penova, T. Kawaguchi, H. Nakamura, N. Hama, K. Shide, Y. Kubuki, T. Hidaka, T. Kameda, T. Nakamaki, K. Ishiyama, S. Miyawaki, S.S. Yoon, K. Tobinai, Y. Miyazaki, A. Takaori-Kondo, F. Matsuda, K. Takeuchi, O. Nureki, H. Aburatani, T. Watanabe, T. Shibata, M. Matsuoka, S. Miyano, K. Shimoda, and S. Ogawa, Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet 47 (2015) 1304-15."},{"key":"68","unstructured":"68\uff09 C. Alfieri, and J.H. Joncas, Biomolecular analysis of a defective nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection. J Virol 61 (1987) 3306-9."},{"key":"69","unstructured":"69\uff09 S. Mine, T. Hishima, A. Suganuma, H. Fukumoto, Y. Sato, M. Kataoka, T. Sekizuka, M. Kuroda, T. Suzuki, H. Hasegawa, M. Fukayama, and H. Katano, Interleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targets. Sci Rep 7 (2017) 10188."},{"key":"70","unstructured":"70\uff09 A.L. Palser, N.E. Grayson, R.E. White, C. Corton, S. Correia, M.M. Ba Abdullah, S.J. Watson, M. Cotten, J.R. Arrand, P.G. Murray, M.J. Allday, A.B. Rickinson, L.S. Young, P.J. Farrell, and P. Kellam, Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection. J Virol 89 (2015) 5222-37."},{"key":"71","unstructured":"71\uff09 H. Iizasa, B.E. Wulff, N.R. Alla, M. Maragkakis, M. Megraw, A. Hatzigeorgiou, D. Iwakiri, K. Takada, A. Wiedmer, L. Showe, P. Lieberman, and K. Nishikura, Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J Biol Chem 285 (2010) 33358-70."},{"key":"72","doi-asserted-by":"crossref","unstructured":"72\uff09 X. Lin, M.H. Tsai, A. Shumilov, R. Poirey, H. Bannert, J.M. Middeldorp, R. Feederle, and H.J. Delecluse, The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells. PLoS Pathog 11 (2015) e1005344.","DOI":"10.1371\/journal.ppat.1005344"},{"key":"73","unstructured":"73\uff09 Y. Narita, T. Murata, A. Ryo, D. Kawashima, A. Sugimoto, T. Kanda, H. Kimura, and T. Tsurumi, Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication. J Virol 87 (2013) 2120-7."},{"key":"74","unstructured":"74\uff09 Y. Narita, A. Sugimoto, D. Kawashima, T. Watanabe, T. Kanda, H. Kimura, T. Tsurumi, and T. Murata, A Herpesvirus Specific Motif of Epstein-Barr Virus DNA Polymerase Is Required for the Efficient Lytic Genome Synthesis. Sci Rep 5 (2015) 11767."},{"key":"75","unstructured":"75\uff09 Z.G. Xu, K. Iwatsuki, N. Oyama, M. Ohtsuka, M. Satoh, S. Kikuchi, H. Akiba, and F. Kaneko, The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer\/T-cell lymphomas. Br J Cancer 84 (2001) 920-5."},{"key":"76","doi-asserted-by":"crossref","unstructured":"76\uff09 J. Zuo, W.A. Thomas, T.A. Haigh, L. Fitzsimmons, H.M. Long, A.D. Hislop, G.S. Taylor, and M. Rowe, Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2. PLoS Pathog 7 (2011) e1002455.","DOI":"10.1371\/journal.ppat.1002455"}],"container-title":["Uirusu"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/69\/1\/69_13\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T19:06:24Z","timestamp":1617303984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/69\/1\/69_13\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.69.13","relation":{},"ISSN":["0042-6857","1884-3433"],"issn-type":[{"value":"0042-6857","type":"print"},{"value":"1884-3433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}